# Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration

> **NCT02350725** · PHASE1,PHASE2 · COMPLETED · sponsor: **scPharmaceuticals, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Furosemide injection solution for subcutaneous administration (80 mg)
- **DRUG:** Oral Furosemide tablets (80 mg)

## Key facts

- **NCT ID:** NCT02350725
- **Lead sponsor:** scPharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02350725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02350725, "Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02350725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*